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Abstract
Background: Pancreas disease (PD), caused by salmonid alphavirus (SAV), is an important disease affecting salmonid
aquaculture. It has been speculated that Atlantic salmon post-smolts are more prone to infections in the first few
weeks following seawater- transfer. After this period of seawater acclimatization, the post-smolts are more robust and
better able to resist infection by pathogens. Here we describe how we established a bath immersion (BI) model for
SAV subtype 3 (SAV3) in seawater. We also report how this challenge model was used to study the susceptibility of
post-smolts to SAV3 infection in two groups of post-smolts two weeks or nine weeks after seawater - transfer.
Methods: Post-smolts, two weeks (Phase-A) or nine weeks (Phase-B) after seawater- transfer, were infected with SAV3
by BI or intramuscular injection (IM) to evaluate their susceptibility to infection. A RT-qPCR assay targeting the non-
structural protein (nsP1) gene was performed to detect SAV3-RNA in blood, heart tissue and electropositive-filtered
tank-water. Histopathological changes were examined by light microscope, and the presence of SAV3 antigen in
pancreas tissue was confirmed using immuno-histochemistry.
Results: Virus shedding from the Phase-B fish injected with SAV3 (IM Phase-B) was markedly lower than that from IM
Phase-A fish. A lower percentage of viraemia in Phase-B fish compared with Phase-A fish was also observed. Viral RNA
in hearts from IM Phase-A fish was higher than in IM Phase-B fish at all sampling points (p < 0.05) and a similar trend
was also seen in the BI groups. Necrosis of exocrine pancreatic cells was observed in all infected groups. Extensive
histopathological changes were found in Phase-A fish whereas milder PD-related histopathological lesions were seen
in Phase-B fish. The presence of SAV3 in pancreas tissue from all infected groups was also confirmed by immuno-
histochemical staining.
Conclusion: Our results suggest that post-smolts are more susceptible to SAV3 infection two weeks after seawater-
transfer than nine weeks after transfer. In addition, the BI challenge model described here offers an alternative SAV3
infection model when better control of the time-of-infection is essential for studying basic immunological mechanisms
and disease progression.
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Background
Pancreas disease (PD) adversely affects the production of
salmonids in many countries in Europe and North
America, and is caused by an alphavirus commonly re-
ferred to as salmon pancreas disease virus (SPDV) or
salmonid alphavirus (SAV). PD was initially recognized
in Scotland in 1976 [1], and has been described in North
America [2], Norway [3], Ireland [4], France, and Spain
[5]. In Norway, PD outbreaks are mainly seen in the
seawater phase of Atlantic salmon and rainbow trout
aquaculture [6]. The alphavirus genome is composed of
genes encoding non-structural proteins (nsP1-nsP4) for
viral replication and structural proteins (E1-E3, capsid and
6K) [7]. Six subtypes of SAV (SAV1-SAV6) have been
identified based on partial E2 and nsP3 genes [8]. Before
2011, only SAV3 had been associated with diagnosed PD-
cases in Norway [6, 9]. In 2011, SAV subtype 2 (SAV2)
was first detected in Norway [10] and its introduction was
traced back to 2010 [11]. Since then, the number of SAV2
outbreaks has been increasing, although the severity of
the disease associated with SAV2 is reportedly less severe
than that caused by SAV3 [11, 12].
Smoltification, or parr-smolt transformation, is a com-
plex biological process preparing salmonids for the sea-
water stage of their lifecycle. Smoltification involves
profound biological changes to the endocrine, osmo-
regulatory, and immune systems resulting in alterations
in morphology, physiology, and behaviour that prepares
salmonids for life in the ocean [13]. During smoltifica-
tion, growth hormone and cortisol act in synergy to
improve the hypo-osmoregulatory ability of Atlantic sal-
mon [14]. Gill Na+, K+-ATPase (NKA) activity is crucial
to osmoregulatory adjustment in fish and it is used as an
indicator of completion in smoltification [15]. Osmo-
regulatory system could be affected by viral infection
[16]. After introduction to the marine environment, sub-
stantial changes in several components of the immune
system have been observed: significant changes in the
composition of leukocyte populations [17] and an in-
crease in the concentration of total serum IgM [18] have
been reported. Accordingly, it has been suggested that
the initial period following seawater transfer is a time of
high energy-demand, during which the fish are more
susceptible to other stressors such as pathogens. After
acclimatization to the marine environment is complete,
post-smolts may be more robust and better able to han-
dle stressors.
In order to gain a fundamental biological understand-
ing of the immune response of salmon post-smolts to
SAV3, a challenge model mimicking the infection in the
field is vital. Intraperitoneal injection (i.p.) and intramus-
cular injection (i.m.) are commonly used in SAV chal-
lenge models [19–22]. The advantages of these methods
are that the success of infection can, to some extent, be
guaranteed, and time-of-infection and viral doses can be
accurately controlled. However, neither i.p. nor i.m. in-
jections represent the true natural route of infection, as
the virus bypasses the host's first line of defense, such as
skin and mucosal mucus. Cohabitation challenge has
also been successfully used to mimic natural exposure to
SAV [11, 23, 24]. However, the time-of-infection and the
viral dose cannot be completely controlled when using a
cohabitation model. Bath immersion (BI) is an alterna-
tive strategy that also mimics the natural exposure to
water-borne virus. It was demonstrated that experimen-
tally infected Atlantic salmon shed virus into the tank-
water during the viraemic period [20]. Hence, the
present study applied this knowledge to establish a BI
challenge model for SAV3. BI can be a promising alter-
native model system to better study natural routes of
infection, and gives the possibility to better control the
viral dose and time-of-infection.
In the present study, we established a BI challenge
model for SAV3 in seawater in order to investigate
whether post-smolts were more susceptible to infection
at either 2 weeks or 9 weeks after seawater-transfer.
Here, we report virus shedding in water, viraemic period,
viral load in the heart, and histopathological changes in
the two groups of post-smolts following BI or IM chal-
lenge with SAV3 in seawater.
Methods
Fish and rearing conditions
The fish used in the present study were non-vaccinated At-
lantic salmon post-smolts from the Aquagen strain, which
had been produced as under-yearling smolts [25, 26] at the
Institute of Marine Research (IMR) in Matre, Western
Norway. The fish population was screened and confirmed
to be negative for SAV3 and piscine reovirus (PRV). Two
separate batches of fish from the same production cycle
were transported to the rearing and disease challenge facil-
ity at IMR in Bergen. The first batch of freshwater smolts
(average weight of 40.9 ± 6.5 g) was transferred into sea-
water upon arrival in Bergen (in early September 2013)
and acclimatized in seawater for two weeks before infec-
tion experiments commenced. Thus, this first batch of ex-
perimental fish was challenged with SAV3 in the initial
period after seawater transfer, and is hereafter referred to
as Phase-A fish. The second batch of post-smolts (aver-
age weight of 88.8 ± 14.0 g) was transferred to Bergen
(in October 2013) after being reared in seawater at
Matre for seven weeks. Hence, this second batch of
post-smolts was in a later period after seawater transfer
and is hereafter referred to as Phase-B fish.
At IMR in Bergen, the fish from each batch were
randomly distributed into 12 identical 250 L seawater
tanks (12 °C, 34.5‰). Each tank contained 65 fish. The
tanks were supplied with aeration (oxygen saturation
Jarungsriapisit et al. Virology Journal  (2016) 13:66 Page 2 of 14
of >85 %) and the water flow was maintained at 400 litres per
hour (Lh−1). The fish were acclimatized in the experimental
tanks for one week before SAV3 infection of shedders and for
two weeks before SAV3 experimental challenges. The fish
were fed twice daily to satiation with a commercial salmon
feed (Spirit Supreme, Skretting, Norway). The fish were
starved for 24 h prior to each sampling. The fish were bath
anaesthetized with a mixture of metomidate (10 mg L−1) and
benzocaine (60 mg L−1) before handling and injection, and
euthanized with a mixture of metomidate (10 mg L−1) and
benzocaine (160 mg L−1) before tissue sampling.
Salmonid alphavirus (SAV)
Chum salmon heart-1 (CHH-1) cells were cultivated in
75 cm2 plastic cell culture flasks containing Leibovitz's L-15
medium (L-15) (Life Technologies, UK) supplemented with
10 % (v/v) foetal bovine serum (FBS) (PAA, France) at
20 °C. A SAV3 isolate from Atlantic salmon heart [27] was
cultivated using CHH-1 cells in L-15 supplemented with
2 % FBS at 15 °C. The virus was harvested at 7 days post-
infection (dpi) when the cytopathic effect (CPE) was ob-
served. Quantification of virus stock was performed using
the end-point dilution assay, and 50 % tissue culture infec-
tious dose (TCID50) was calculated [28]. After this experi-
ment was completed we discovered that the SAV3 isolate
used was contaminated with low levels of infectious pancre-
atic necrosis virus (IPNV), as the isolate had earlier been
passed through one round of infection in fish. However,
IPNV contamination levels were relatively low (6 Ct values
higher than SAV3). Anterior kidneys of IM Phase-A and BI
Phase-A fish at 7, 14, 21 and 28 dpi were, therefore, ana-
lyzed for the presence of IPNV [29]. Twenty-five percent of
the tested IM Phase-A fish were positive for relatively low
levels of IPNV (average Ct value of 36), but all of the tested
BI Phase-A fish were negative. Hence, co-infection with
IPNV is not likely to have a major effect on the interpret-
ation of the results of this study.
Experimental design
Both Phase-A and Phase-B experiments had a similar de-
sign, which is outlined in Fig. 1. One and eight weeks after
seawater transfer of Phase-A and Phase-B fish, respectively,
all the fish in 3 of the 12 tanks from each experiment were
i.m. injected in the muscle in front of the dorsal fin and
above the lateral line with 2 x 50 μl of SAV3. The titer of
SAV3 in Phase-A and Phase-B was similar in the range of
2.0-3.7 x104 TCID50 per fish. These fish served as shedder
fish, whose purpose was to shed SAV3 into the tank-water.
The water in these tanks (referred to as shedder tanks) was
monitored for the presence of SAV3 by RT-qPCR. On the
day of challenge, 7 days (in Phase-A) and 8 days (in Phase-
B) after injection of shedder fish, three treatment groups in
triplicate tanks were created: (i) fish i.m. injected with cell
culture medium from uninfected CHH-1 cells, serving as
non-infected control (referred to as ‘CT group’); (ii) fish i.m.
injected with SAV3 (referred to as the ‘IM group’); (iii) fish
infected by bath immersion in seawater (as described below)
containing SAV3 (referred to as the ‘BI group’). The IM
groups in Phase-A and Phase-B were given relatively similar
titer of SAV3 (2.6–3.7x104 TCID50 per fish). The experi-
ments were carried out in strict accordance with guidelines
and approved by Norwegian Animal Research Authority
(NARA).
Bath immersion (BI) challenge model
The BI groups were bathed in seawater from the shedder
tanks as follows. The water flow in the 3 shedder tanks
was stopped for one hour, and the tanks were supplied
with extra aeration. After this 1 h period, the shedder
fish were removed from the tanks and replaced by new
Fresh
water
Phase-A Phase-B
Average weight 88.8±14.0  g
Seawater 
transfer
(0 wpt)
7 week interval 
Average weight 40.9±6.5  g
1 wpt
Shedder
2 wpt
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8 wpt 9 wpt
Control (CT) 
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i.m. injection (IM)
CT 
BI 
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Same Production Batch
Fig. 1 Experimental setup. Susceptibility to salmonid alphavirus subtype 3 (SAV3) of Atlantic salmon (Salmo salar L.) 2 weeks (Phase-A) or 9 weeks (Phase-B)
post seawater- transfer (wpt). Triplicate tanks of shedder fish were intramuscularly (i.m.) injected with SAV3 approx. 1 week before the day of experimental
challenges in order to obtain seawater containing SAV3 for BI challenge. Three treatments, control (CT), i.m. injection (IM) and bath immersion (BI) were
performed in triplicate tanks. Arrows indicate the time of experimental SAV3 infection challenges
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fish. These BI fish were kept in the aerated shedder tanks
with no water flow for six hours. The oxygen level in all
tanks was closely monitored when the water flow was
stopped. After 6 h of bath immersion, the water flow was
resumed with normal aeration, which diluted out and re-
moved the remaining virus in the tanks within a short time.
Water sampling
Seawater sampling from the tanks, and up-concentration
of SAV3 from the seawater samples, was performed [18]
with some modifications. This water filtration technique is
based on the VIRADEL (virus-adsorption-elution) method
[30, 31] carried out by using electropositive, charge-
modified, glass and cellulose (1MDS) filters [32, 33]. Briefly,
one litre of seawater was collected from the tanks using
sterile autoclaved screw-cap 1 L glass bottles. The water
samples were vacuum filtered at a flow of 70–100 ml min−1
using a glass filtration system (MilliPore, USA.) through
electropositive Zeta Plus™ 1MDS filters (Cuno Inc, USA.).
After filtration, the filters were placed upside down in
55 mm petri-dishes containing 1 ml of lysis buffer (iPrep™
PureLink® Total RNA Kit, Invitrogen, USA.), and agitated
at 500 rpm for 15 min on an orbital shaker. Four hundred
microliters of the eluant was then transferred into a 1.5 ml
tube and stored at -80 °C for RT-qPCR.
In the Phase-A experiment, water was collected from
tanks containing IM fish at 2, 4, 6, 8, 10, 14, 18, 23 and
28 dpi, while water was collected from tanks containing
the CT fish at 2, 4, 7, 10, 18 and 28 dpi. Water sampling
in Phase-B was optimised based on the viral shedding
profile seen in IM and CT groups in Phase-A. In the
Phase-B experiment water was collected from tanks con-
taining IM fish at 4, 8, 15 and 20 dpi, while water from
tanks containing BI fish was collected at 1, 3, 5, 7, 10, 14
and 21dpi, and from tanks containing CT fish at 1, 8
and 15 dpi.
Tissue sampling
Eight fish per tank per sampling point were euthanized
as previously described, and length and weight were re-
corded before blood and tissue sampling. Blood was col-
lected at 1, 3, 7, 10, 14, 21, and 28 dpi in Phase-A with
heparinized syringes (for plasma) and Phase-B without
anticoagulant (for serum) from the caudal vein. Plasma
and sera were collected by centrifugation (9500 g,
10 min) within 3 h of sampling or after storage at 4 °C
overnight, respectively. Gills from Phase-A fish were
sampled and analyzed for Na+, K+-ATPase (NKA) activ-
ity at 1, 3, 7, 10, 14, 21 and 28 dpi by collecting gill fila-
ments in 100 μl of ice-cold SEI buffer (150 mM sucrose,
10 mM EDTA, 50 mM imidazole, pH 7.3) and snap
freezing in liquid nitrogen. Since Phase-B fish were ex-
pected to be stabilized and little influence of infection
was expected, gills from these fish were not analysed for
NKA activity. Hearts were collected at 3, 7, 14, 21, and
28 dpi for RT-qPCR analysis. Hearts from day 7, 14, 21
and 28 were cut in two longitudinally and the half that
included the ventricle with bulbus arteriosus was snap
frozen in liquid nitrogen while the other half including
the atrium from four fish per tank was fixed in 10 %
neutral buffered formalin. Plasma, sera, gill filaments
and hearts were stored at -80 °C until further analyses.
In addition, pancreatic tissue associated with pyloric
caeca was sampled from four fish per tank at 7, 14, 21,
and 28 dpi and fixed in 10 % neutral buffered formalin.
RNA extraction and RT-qPCR
Total RNA was extracted from a homogenate of
approx. 50 mg of heart tissue using an iPrep™ PureLink®
Total RNA Kit (Invitrogen, USA.) with TRIzol® reagent
(Ambion). The RNA isolation from filtered water elu-
ants, plasma and serum samples was performed using
the same kit with lysis buffer, according to the manu-
facturer’s instructions. The isolated RNA from plasma
samples was lithium chloride precipitated to remove
heparin which interfered with RT-qPCR. The AgPath-
ID One-Step RT-qPCR Kit from Ambion, Life Tech-
nologies and a RT-qPCR assay targeting the SAV nsP1
gene were used for detection of SAV3 [34] with the
following modification of the probe sequence FAM-5'-
TCGAAGTGGTGGCCAG-MGB. The assay was per-
formed with 200 ng of RNA (heart) or 2 μl of isolated
RNA (plasma, sera and water), 400 nM of forward pri-
mer, 600 nM of reverse primer and 160 nM of probe in
a total volume of 7 μl on a 384 well-plate. Amplification
and fluorescence detection were measured by a 7900
HT Fast Real-Time PCR system (Applied Biosystems)
as recommended by the manufacturer. The threshold
value for all samples was set to 0.1 and the amplifica-
tion was run for 40 cycles. The elongation factor 1A
(EFIAA) [35] was checked from a random selection of
25 % of heart samples from infected treatment groups
representing all time-points of sampling to validate
the quality of the RNA samples and all the samples
showed stability and satisfactory levels of EFIAA (Ct
value of 21–22).
Analysis of Na+,K + -ATPase (NKA) enzyme activity
In the Phase-A experiment, we analysed the NKA ac-
tivity of gill filament samples from 12 fish per treat-
ment at each time-point (1, 3, 7, 10, 14, 21, and 28
dpi) as representatives of each tank as described pre-
viously [15]. The NKA activity is expressed as μmol
ADP mg protein−1 h−1.
Analysis of plasma cortisol
On each sampling day, plasma samples from 12 individ-
ual fish in each treatment group from both Phase-A and
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Phase-B experiments were analyzed for cortisol concen-
tration by ELISA according to the manufacturer’s rec-
ommendations (IBL International, Hamburg, Germany).
Histology and immunohistochemistry (IHC)
The pancreas and heart tissues from all groups were
fixed in 10 % neutral buffered formalin for 2 days before
being processed and embedded in paraffin wax. Samples
selected from fish with SAV3-positive hearts (identified
using RT-qPCR) were sectioned at 3 μm using a Leica
RM 2255 microtome (Leica Microsystems, Germany)
and placed on SuperFrost® Plus slides (Menzel-Gläser,
Germany). Selected histological sections (n = 3-9 from
each group per sampling point of Phase-A and n = 2–4
from each group per sampling point of Phase-B) were
stained with Haematoxylin-Erythrosin-Saffron (HES).
The selected tissue sections were stained with an anti-E2
antibody to confirm the presence of SAV3. The paraffin
sections were incubated at 60 °C for 30 min followed by
de-waxing and dehydration with alcohol series and water.
Antigen retrieval was carried out in 10 mM citrate buffer
(pH 6.0) for 20 min followed by transferring to Tris-
buffered saline (TBS, pH 7.4) using a 2100 Retriever
model pressure cooker (Prestige Medical, England) ac-
cording to the manufacturer’s instructions to unmask
antigens. Blocking of non-specific antibody binding to sec-
tions was performed by using 5 % bovine serum albumin
(BSA) in TBS for 20 min. All wash steps were carried out
with TBS for 5 min until counterstaining. The primary
antibody, a rabbit polyclonal anti-E2, was diluted 1: 200 in
TBS containing 2.5 % BSA, and applied to the sections
and incubated at 37 °C for 1 h, followed by biotinylated
anti-mouse/rabbit immunoglobulin G, secondary anti-
body, and avidin-biotin alkaline phosphatase according to
manufacturer’s recommendation (Vectastain universal
ABC-AP kit; Vector Laboratories, California, USA).
Sections were stained with the fuchsin substrate and
chromogen system (Dako North America Inc., USA) and
counterstained with Shandon’s haematoxylin. Positive im-
munostaining was visualised microscopically as a red/ma-
genta colouration.
Data and statistical analysis
Fulton’s condition factor was calculated by 100 ×
weight (g)/ [fork length (cm)]3. The Ct values of heart
samples, gill NKA activities and plasma cortisol levels
were imported into Statistica 12 (StatSoft, Inc., OK,
USA). Differences in SAV3 RNA levels in the hearts
of IM Phase-A and Phase-B fish were tested with a
Mann-Whitney U non-parametric test, whereas One-
way ANOVA was applied to NKA activity and plasma
cortisol data.
Results
SAV3 challenges
Both Phase-A and Phase-B Atlantic salmon post-smolts
were successfully infected with SAV3 in seawater via the
i.m. injection route (IM group) and bath immersion
route (BI group). No mortality was observed during the
experimental period. SAV was not detected in the fish
batch prior to the start of this experiment. However, 6
out of the 238 fish from the control group (CT) were
subsequently found to be SAV-positive. Exposure to
SAV during early life stages (before the transfer to Ber-
gen and the start of the experiment) might have resulted
in a very low prevalence of SAV, below the detection
limit of our screening method, in our experimental fish
population. Cross-contamination during fish/sample
handling may also be a possible cause of this result.
Condition factor
Fulton’s condition factors during the course of the ex-
periment were in the range of 0.93–1.07 and 1.09–1.17
in Phase–A and Phase-B fish, respectively. The condition
factor of IM Phase-A fish from 10 dpi onward was lower
than the CT Phase-A and BI Phase-A fish with a signifi-
cant difference at 28 dpi (p < 0.05, Additional file 1). No
differences in condition factors were observed between
groups in the Phase-B experiment.
Gill NKA activity
Gill NKA activity of Phase-A post-smolts was 12–
18 μmol ADP mg protein−1 h−1 (Additional file 2). The
BI Phase-A fish showed significantly lower gill enzyme
activity than those observed in the CT Phase-A fish at
28 dpi (p < 0.05; Additional file 2). Nevertheless, gill
NKA activity levels were within normal range for post-
smolts [36].
Plasma cortisol
Plasma cortisol concentrations were relatively high in all
groups (5.6–30.2 ng/ml in Phase-A, and 7.3–30.8 ng/ml
in Phase–B fish, respectively). In Phase-A fish, the
plasma cortisol concentrations in the CT group were
significantly higher than the IM and BI groups at 1 dpi
(p < 0.05) (Additional file 3). In the Phase-B experiment,
plasma cortisol concentrations of BI Phase-B fish were
significantly higher than CT Phase-B and IM Phase-B
fish at 1 dpi (p < 0.05). BI Phase-B fish also showed sig-
nificantly higher levels of plasma cortisol than IM
Phase-B fish at 7 dpi (p < 0.05) (Additional file 3).
Virus shedding
Prior to the start of the BI challenge, viral shedding from
the shedder fish was monitored (Fig. 2a). In Phase-A,
SAV3 could be detected in the tank water at the first
sampling time point (4 dpi). Levels of SAV3 in the water
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were increased on day 6 and again on day 7. On day 7
the shedder fish were removed and the fish to be chal-
lenged were added to the tank as described. In Phase-B,
the amount of virus was low or undetectable up until 6
dpi. By 8 dpi the level of virus had started to increase. In
Phase-B, the shedder fish were removed from the tank
at 8 dpi, and the challenge performed as described.
Interestingly, Phase-A shedder fish shed significantly
more SAV3 than the Phase-B shedder fish.
During the challenge experiments, virus shedding was
monitored from CT Phase-A and -B fish, IM Phase-A and
-B fish, and BI Phase-B fish (Fig. 2b). SAV3 was not de-
tected in water samples from tanks containing the CT
Phase-A and -B fish. SAV3 was detected in water from the
IM Phase-A fish at 6 dpi, and peaked at 8 dpi. There was
a considerable decrease in SAV3 levels from 10 dpi, and
sporadic detection of SAV3 was observed at later time
points until the end of the study at 28 dpi. In the Phase-B
experiment, SAV3 shedding was detected from the IM
Phase-B fish at 8 dpi (1 of 3 replicate tanks), and from the
BI Phase-B fish at 14 dpi (2 out of 3 replicate tanks). Simi-
lar to the results from the shedder fish, the IM Phase-A
fish shed higher levels of SAV3 than the IM Phase-B fish.
Shedding from IM Phase-A fish also lasted for a longer
time, than the shedding from IM Phase-B fish.
Viraemia
SAV3 RNA was detected at 7 dpi in blood samples of all
groups exposed to SAV3 (Table 1). Comparison of viral
load in blood between Phase-A and Phase-B fish showed
that the percentage of Phase-B fish with viraemia was
lower than Phase-A (Table 1).
SAV3 in the heart
SAV3 was detected in the hearts of IM and BI Phase-
A fish, and in hearts from IM Phase-B fish at all sam-
pling time-points while in hearts from BI Phase-B fish
it was detected from 14 dpi (Fig. 3). The viral load in
hearts from the IM Phase-A fish was significantly
higher than that of IM Phase-B fish at all sampling
time-points (p < 0.05) (Fig. 4). Interestingly, the viral
load in the IM Phase-A fish, which peaked at 14 dpi,
was lower than the viral load in the BI Phase-A fish at
21 dpi (Fig. 4). The percentage of positive fish was
higher in IM Phase-A (50 %) than in IM Phase-B
(33 %) at 3 dpi, and similarly high percentages of posi-
tive fish (88–100 %) were detected in both groups at
later time-points (7, 14, 21 and 28 dpi) (Fig. 5). The
percentage of positive individuals at 3 dpi was much
lower in the BI Phase-A fish (8 %) than in the IM
Phase-A fish (50 %), but it also reached nearly 100 %
from 14 dpi (Fig. 5). There was a marked difference in
the number of positive fish between BI Phase-A and
BI Phase-B treatment groups (Fig. 5). In the BI Phase-
B group, relatively few positive fish (17–29 %) were
detected throughout the experiment (Fig. 5).
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Fig. 2 SAV3 detected in the tank-water by RT-qPCR. a, from tank containing shedder fish (♦) in Phase-A (solid line) and Phase-B (dashed line).
Mean Ct value ± SEM; n = 1-3. b, from tanks containing the IM and BI groups. Viral shedding into the water from IM (▲) Phase-A (solid line),
Phase-B (dashed line), and BI Phase-B (●) post-smolts at each time point. Mean Ct value ± SEM; n = 1-3. Ct value of 40 was set as negative
Table 1 Number of fish with viraemia
IM BI
Phase-A 16/18 7/15
(89 %) (47 %)
Phase-B 12/15 2/15
(80 %) (13 %)
Plasma (Phase-A) or serum (Phase-B) samples of IM and BI treatments at 7 dpi
analyzed. The values represent the number of positive samples/number of
analyzed samples, and percentage of positive samples (in brackets)
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Histopathology
Histopathological changes in pancreas and heart tissue of
SAV3-positive fish from all SAV3-exposed groups was ex-
amined, and the presence of SAV3 was confirmed by im-
munohistochemistry (IHC). Extensive necrosis of exocrine
pancreatic cells, and degeneration of myocardial cells in the
heart, was observed in IM Phase-A and BI Phase-A fish
with differences in time of onset (Figs. 6 and 7). At 7 dpi,
necrosis of exocrine pancreatic tissue and detection of
SAV3 was observed in the IM Phase-A fish (Fig. 6c-d),
whereas pancreatic tissue in the BI Phase-A fish showed a
relatively normal histological appearance regardless of the
presence of SAV3 in pancreatic tissue (Fig. 6e-f). Overall, a
similar degree of severity of PD-associated histopathological
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except at: 14 dpi of BI Phase-A (n = 21), 7 dpi of IM Phase-B (n = 22), and 28 dpi of IM Phase-B (n = 23). Ct value of 40 was set as negative
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points of BI Phase-B where n= 2–7 (as very few fish were SAV3 positive)
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changes in the pancreas and heart from IM Phase-A fish
was also seen in the BI Phase-A fish approximately one
week later. Significant necrosis of exocrine pancreatic tissue
occurred at 7 dpi in the IM Phase-A fish (Fig. 6c-d) and at
14 dpi in the BI Phase-A fish (Fig. 6i-j). Focal myocardial
degeneration was seen at 7 dpi in the IM Phase-A fish
(Fig. 7c) and at 14 dpi in the BI Phase-A fish (Fig. 7f). Se-
vere diffuse myocardial degeneration was observed at 14
dpi in the IM Phase-A fish (Fig. 7d). Both IM and BI
Phase-B fish showed mild histopathological changes in the
pancreas and infiltration of inflammatory cells (Fig. 8c-f)
could be seen when compared to Phase-A fish (Fig. 6c-j).
Discussion
Here, we report that a BI model for SAV3 infection of At-
lantic salmon in seawater was successfully established. To
the best of our knowledge, this is the first report of a SAV3
BI challenge model for Atlantic salmon post-smolts in sea-
water. While injection (i.m. or i.p.) challenge models for
SAV3 (and many other viruses) provide control of viral
dose and time-of-infection, they do not represent the true
natural route of infection. On the other hand, cohabitation
challenge models mimic natural route of exposure, but con-
trol of viral dose and time-of-exposure is inferior to the in-
jection challenge model. Importantly, the bath immersion
model established in the present study also allows natural
exposure of challenged fish to SAV3. In contrast to
cohabitation challenge, our bath immersion model gives a
more accurate estimation of time-of- exposure by limiting
the time-window to 6 h. Furthermore, an additional advan-
tage over co-habitation models is that our BI model gives
better control of the viral dose that the fish are actually ex-
posed to during the 6-h window compared to cohabitation
challenge model where exposure occurs over the period of
viral shedding, possibly several days.
In this study, two groups of Atlantic salmon from the
same production batch were challenged with SAV3, by
i.m. injection or by bath immersion, 2 weeks (Phase- A)
or 9 weeks (Phase- B) after seawater transfer (Fig. 1). In-
jection of SAV3 showed that there were differences in
viral shedding, viral load in the heart, and degree of
histopathological changes in various tissues between
Phase-A and -B fish. Unsurprisingly, since all fish were
injected with virus, the prevalence of SAV3 positive fish
in the Phase-A and -B groups was rather similar. How-
ever, when Phase-A and -B fish were challenged with
SAV3 using the newly established BI challenge model
(that mimics the natural exposure to water-borne virus),
variation in all of the parameters mentioned above, in-
cluding the number of SAV3 positive fish, was seen.
In the BI model the exposure dose relies on the amount
of SAV3 shed from the shedder fish. Our results show that
shedder fish from Phase-A, which were injected with
SAV3 1 week after seawater-transfer shed more virus than
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the shedders from Phase-B, which were injected 8 weeks
after seawater transfer (average Ct value in water of 28
and 34, respectively, Fig. 2a). Thus, the BI fish in Phase-A
were exposed to a greater amount of virus than the BI fish
in Phase-B. This may explain the differences observed be-
tween Phase-A and -B fish using the BI challenge model.
Our data therefore suggest that using small post-smolts in
the first weeks after seawater transfer as shedder fish is an
optimal solution for obtaining maximum and most con-
sistent virus shedding.
We also note that a “cohabitation effect” may also have
occurred in the Phase-B BI challenge since there was a mix-
ture of infected and possibly naive individuals in the popu-
lation throughout the experimental period. Therefore, the
length of the experiment would have theoretically allowed a
second exposure to SAV3 shed from the few fish that were
infected in the first round of exposure. This likely reflects
how the virus is transmitted in the field. If required, it may
be possible to prevent this second round of exposure in the
BI model by optimizing the initial infection dose or by
(See figure on previous page.)
Fig. 6 HES and IHC staining of pancreas from Phase-A post-smolts. a and b, CT group at 7 dpi; normal pancreatic tissue in Atlantic salmon with endocrine
pancreatic tissue (arrow), exocrine pancreatic tissue with zymogen granules (*) and fat tissue (arrowhead) without red colour staining from IHC indicating
the absence of SAV. c and d, IM group at 7 dpi; necrosis of exocrine pancreatic tissue with the presence of SAV confirmed by IHC. e and f, BI group at 7
dpi; normal appearance of pancreatic tissue, but the presence of SAV shown by IHC. g and h, IM group at 14 dpi; mononucleated cells (macrophage-like
or fibroblast-like cells) replaced normal pancreatic tissue and weak staining for SAV by IHC. i and j, BI group at 14 dpi; necrosis of exocrine pancreatic tissue
and strong staining for SAV by IHC. a, c, e, g, and i, HES staining. b, d, f, h, and j, IHC staining. Bar 50 μm. The insets were at 200x
a b
c d
e f
* *
Fig. 7 HES staining of heart from Phase-A post-smolts at 7 dpi and 14 dpi. a and b, CT group; normal heart tissue in Atlantic salmon showing
cardiomyocytic cells in compact (*) and spongy (arrow) layers. c and d, IM group; focal (c) and severe diffused (d) myocardial degeneration.
e and f, BI group; normal appearance of heart tissue (e) and focal myocardial degeneration (f).a, c, and e, 7 dpi; b, d, and f, 14 dpi. Arrowhead
shows necrosis of myocardiocytes. Bars 50 μm. The insets were at 200x
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limiting the duration of the study. However, studying the
viral shedding profile of fish infected with SAV3 via BI may
also be very important for understanding virus transmission
from fish-to-fish in a field situation. Such studies will be
useful for developing management strategies during PD
outbreaks. Thus, the BI model described here may contrib-
ute to a better understanding of field outbreaks of viral
diseases and provide a greater insight into salmon immune
responses to SAV3.
Virus shedding is an indicator of viral infection and
multiplication in the host. Previously, it has been dem-
onstrated that SAV3 is shed into the water through
mucus and faeces [37], and that there is a positive cor-
relation between viraemia and virus shedding [20, 23].
Our results showed that IM fish in Phase-A shed
more virus than IM fish in Phase-B. This suggests
that SAV3 multiplication was more efficient in Phase-
A fish and, therefore, more virus particles were shed.
It is worth noting that detection of SAV3 from water
samples using VIRADEL method followed by RT-
qPCR has its limitations. In the Phase-A study we ob-
served sporadic detection of the virus in the water
(after the peak period). The limitations in the sample
collection, sample processing and/or analysis can be
overcome by further optimization.
More fish with viraemia could be detected in the IM
and BI Phase-A fish as compared to IM and BI Phase-B
fish. SAV3 in blood or in tank-water could be detected
for longer period (up to 28 dpi) in Phase-A post-smolts
when the fish were small (41 g). This is similar to previ-
ous results with 40 g salmon parr (up to 105 dpi) [21]. It
appears to be shorter (up to 14 dpi) in bigger post-
a b
c d
e f
Fig. 8 HES and IHC staining of pancreas from Phase-B post-smolts. a and b, control group at 14 dpi; normal pancreatic tissue in Atlantic salmon
with exocrine pancreatic tissue with zymogen granule and fat tissue without red colour staining from IHC indicating the absence of SAV. c and d,
IM group at 7 dpi; necrosis of exocrine pancreatic tissue with the presence of SAV confirmed by IHC. e and f, BI group at 7 dpi; focal pancreatic
acinar cell necrosis with the presence of SAV shown by IHC. a, c, and e, HES staining; b, d, and f, IHC staining. Arrowhead shows infiltration of
inflammatory cells. Bars 50 μm. The insets were at 200x
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smolts (89 g) at later period after seawater transfer
(Phase-B in the present study), as it was also seen in
other published results for 73 g post-smolt (4–13 dpi)
[20], and 120 g (3–14 dpi) [38]. The longer shedding
period in Phase-A post-smolts is likely due, at least in
part, to a reduced capacity to clear the virus in these fish
compared to Phase-B post-smolts. Possibly virus replica-
tion in the muscle tissue [39] has also contributed to the
detection of virus in the water sample at 28 dpi. SAV3
was detected in tank-water and sera from Phase-B BI
fish indicating that the virus was successfully transmitted
by the BI model. Since shedding is a reflection of vir-
aemia, this suggests that shedding of SAV3 by the BI fish
may have occurred at 7 dpi, but that it was most likely
below the detection limit. It is also possible that the peak
of viraemia in the BI fish might occur later than 7 dpi,
since SAV3 was detected in the tank-water from BI
Phase-B fish at 14 dpi.
Quantification of SAV3 nsP1-RNA revealed significant
differences in the viral load in the heart between Phase-
A and -B fish, which may indicate a difference in im-
mune response to SAV3 between these two stages. In
the present study, factors affecting the difference in
immune response could be fish size and/or period after
seawater transfer. Since we used fish from the same pro-
duction batch, differences due to genetic variation
should be minimal. The BI Phase-A fish showed a higher
peak of viral load in the heart than the IM Phase-A fish,
but with a one week time-lag (21 versus 14 dpi). The
route of uptake may play a role here: SAV3 infection via
the water-borne exposure may lead to a greater level of
infection, even though the virus takes a longer time to
multiply and peak, due to the lower number of virus
particles responsible for the initial infection. In support-
ing of this theory, it has been previously reported that
waterborne infection (cohabitation) produced a greater
severity of PD than i.p. injection [11]. The percentage of
positive individuals was similar in IM Phase-A and -B,
whereas substantial differences were seen between the
BI groups from both phases. The percentage of SAV3
positive fish in IM Phase-A and -B were similar because
injection introduced virus directly into the host body.
The histopathology seen in experimentally infected
post-smolts was typical of clinical PD [38, 40]; necrosis
and loss of exocrine pancreatic tissue and degeneration
of cardiomyocytes, where pancreatic necrosis was ob-
served before heart lesions. Phase-A post-smolts in both
IM and BI groups showed more extensive histopatho-
logical changes compared to Phase-B post-smolts reflect-
ing the difference in susceptibility to SAV3 between these
groups. The positive correlation between viral load and
histopathological changes observed in the present study is
in agreement with an earlier report [39]. A strong correl-
ation between viral load and severity of histopathology in
heart was very clear amongst Phase-A post-smolts, with
increasing viral load coinciding with more severe PD
lesions. Phase-B post-smolts appeared to show a similar
trend, but a firm conclusion was difficult to draw due to
SAV3-positive fish from Phase-B showing only mild PD
lesions in heart. The presence of SAV3 in pancreas was
confirmed by IHC, and Phase-A post-smolts displayed
more prominent staining in the pancreas and more severe
PD-related lesions. The most pronounced SAV3 staining
could be seen in the exocrine pancreatic cells showing ne-
crosis similar to a previous study [40]. Interestingly, SAV3
staining was also observed in some exocrine pancreatic
cells of BI Phase-A fish, which were otherwise of normal
appearance, suggesting a very early stage of infection with
a low viral load in the tissues. In addition, infiltration of
inflammatory cells could be seen as early as 7 dpi in
Phase-B post-smolts indicating activation of a cellular
immune response to SAV3.
Taken together the results presented here strongly sug-
gest that: (i) Atlantic salmon post-smolts are highly suscep-
tible to SAV3 infection 2 weeks after seawater transfer
(Phase A fish); and (ii) post-smolts challenged with SAV3
9 weeks after seawater transfer (Phase B fish) are less sus-
ceptible to SAV3 infection. Thus the Phase-A post-smolts
were infected with SAV3 during their initial acclimatization
in seawater when their ability to mount an anti-viral im-
mune response was inferior to Phase-B post-smolts. In pre-
vious studies, differences in susceptibility to SAV3 and
other fish viruses have been attributed to fish strains [38],
age and size [41, 42], or environmental conditions [43]. In
this study genetic variation was minimized by using fish
from the same production batch. Therefore, factors affect-
ing susceptibility between these two post-smolt groups
might be age, size, and/or physiological or immunological
status of the fish after sea water transfer. A combination of
age and size has been shown to affect the virulence
of infectious hematopoietic necrosis virus (IHNV)
resulting in differences in mortality [41]. Smoltifica-
tion is a developmental event involving endocrine,
morphological, physiological and behavioural aspects
that allow salmonids to enter the ocean [13]. After
seawater-transfer, marked changes in the immune sys-
tem have been reported [17, 18]. Directly after
seawater-transfer, post-smolts (Phase-A fish) are utiliz-
ing large amounts of energy acclimatizing to the mar-
ine environment, and may be less able to mount an
effective immune response. Successful adaptation to
the seawater occurs after a few weeks [44], when
post-smolts are more robust and better able to fight a
SAV3 infection (as seen for Phase B fish). Gill NKA activity
from our study was within the normal range so, presum-
ably, no secondary physiological disturbances occurred.
The IM Phase-A fish showed a significant decrease in
Futon’s condition factor at the end of the experiment
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indicating that SAV3 infection contributes to weight loss,
and this has also been shown in previous studies [11, 45].
The statistically significant differences in concentrations of
plasma cortisol may have resulted from a combination of
the handling stress, injections, and viral infection. However,
the concentration of plasma cortisol was similar to previ-
ous reports [44, 46]. A specific trend or substantial effect
of stress, due to disease progression, was not evident in this
study and future studies may benefit from measuring sev-
eral components of the stress-axis, since turnover of corti-
sol may vary with hormone production, receptor
abundance, and clearance of the ligand.
Conclusions
In the present study, a BI challenge model for SAV3 in
seawater was successfully established. Using the IM and
BI challenge models we demonstrated that post-smolts
challenged with SAV3 2 weeks after seawater-transfer
are more susceptible to infection than post-smolts chal-
lenged 9 weeks after seawater-transfer.
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Phase-A experiment. The additional file condition factor.ppt shows
Mean ± SEM from CT (■), IM (▲) and BI (●) groups at each time point
(days post infection), n = 24. (PPT 73 kb)
Additional file 2: Gill NKA activity of Atlantic salmon post-smolt in
Phase-A experiment. The additional file gill NKA activity. ppt shows mean
± SEM from CT (■), IM (▲) and BI (●) groups at each time point (days
post infection). n = 12, except control group at 21 dpi, n = 11. (PPT 75 kb)
Additional file 3: Concentration of plasma cortisol. The additional file
plasma cortisol.ppt shows mean ± SEM from CT (open bar), IM (grey bar)
and BI (diagonal stripe) groups in Phase-A (A) and Phase-B (B) at each
time point (days post infection), n = 11–12. (PPT 82 kb)
Abbreviations
BI: bath immersion; CT: control; Ct value: cycle threshold value; dpi: days post
infection; IM: intramuscular injection; i.m.: intramuscular; i.p.: intraperitoneal;
PD: pancreas disease; Phase-A: two weeks after seawater- transfer; Phase-
B: nine weeks after seawater- transfer; RNA: ribonucleic acid; RT-
qPCR: quantitative reverse transcription polymerase chain reaction;
SAV: salmonid alphavirus; SPDV: salmon pancreas disease virus; wpt: weeks
post seawater- transfer.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JJ, SP, GLT, TON and SS designed the experiment. SP, JJ and LJM conducted the
experiment using post-smolt produced by PGF. ØE kindly provided rabbit
anti-E2 SAV3 antibody used in IHC and SAV3 isolate for starting material of virus
propagation. Sampling of fish tissues and water was mainly performed by SP,
JJ, and LJM. LJM and JJ carried out assay of NKA activity under supervision of
TON and RT-qPCR while IUF, SP and JJ performed histology and IHC. JJ
analyzed the results with guidance from SP, GLT, TON and SS, and wrote the
manuscript. All authors took part in discussion and interpretation of results. JJ,
SP, LJM, SS, TON, and HCM critically revised the manuscript. All authors read,
advised and approved the final manuscript.
Acknowledgements
This work was financially supported by The Norwegian Research Council (224885/
E40) and partially financed by Norwegian Agency for Development Cooperation
(Norad). The authors would like to thank Petter Frost from MSD animal health
innovation, Norway for valuable discussion of experimental design. The authors
also greatly appreciated excellent assistance from IMR staff: Ivar Helge Matre at
Matre research station for production of fish; Joachim Nordbø and Hari Rudra for
monitoring of experimental fish and good advice for fish husbandry; and Ann
Cathrine Bårdsgjære Einen, Cecilie Helen Isachsen, Miriam Castillo Furné, and
Joachim Nordbø for assistance during fish and water sampling; Karen Anita
Kvestad for measurement of plasma cortisol concentration.
Author details
1Institute of Marine Research, Nordnesgaten 50, 5005 Bergen, Norway. 2Uni
Research Environment, Uni Research, Thormøhlensgt., 49 B, 5006 Bergen,
Norway. 3Department of Biology, University of Bergen, P.O. Box 7803 N-5020
Bergen, Norway. 4Institute of Marine Research, Matre Research Station,
Matredal, Norway. 5Norwegian University of Life Sciences, Faculty of
Veterinary Medicine and Biosciences, P.O. Box 8146 Dep, N-0033 Oslo,
Norway.
Received: 14 December 2015 Accepted: 31 March 2016
References
1. Munro ALS, Ellis AE, Mcvicar AH, Mclay HA, Needham EA. An exocrine
Pancreas disease of farmed Atlantic salmon in Scotland. Helgolander
Meeresuntersuchungen. 1984;37:571–86.
2. Kent ML, Elston RA. Pancreas disease in pen-reared Atlantic salmon in north
america. Bull Eur Assoc Fish Pathol. 1987;7:29–31.
3. Poppe T, Rimstad E, Hyllseth B. Pancreas disease in Atlantic salmon (Salmo
Salar) postsmolts infected with infectious pancreatic necrosis virus (IPNV).
Bull Eur Assoc Fish Pathol. 1989;9:83–5.
4. Murphy TM, Rodger HD, Drinan EM, Gannon F, Kruse P, Korting W. The
sequential pathology of Pancreas disease in Atlantic salmon farms in
Ireland. J Fish Dis. 1992;15:401–8.
5. Raynard RS, Houghton G, Munro ALS: Pancreas disease of Atlantic salmon:
proceedings of a European Commission Workshop. In Scottish Office
Aquaculture Report, The Scottish Office Agriculture and Fisheries
Department, Aberdeen, No. 1, p 2-4; 1992
6. Hodneland K, Bratland A, Christie KE, Endresen C, Nylund A. New subtype of
salmonid alphavirus (SAV), Togaviridae, from Atlantic salmon Salmo salar and
rainbow trout Oncorhynchus mykiss in Norway. Dis Aquat Organ. 2005;66:113–20.
7. Weston JH, Welsh MD, McLoughlin MF, Todd D. Salmon pancreas disease
virus, an alphavirus infecting farmed Atlantic salmon, Salmo salar L. Virology.
1999;256:188–95.
8. Fringuelli E, Rowley HM, Wilson JC, Hunter R, Rodger H, Graham DA.
Phylogenetic analyses and molecular epidemiology of European
salmonid alphaviruses (SAV) based on partial E2 and nsP3 gene
nucleotide sequences. J Fish Dis. 2008;31:811–23.
9. Jansen MD, Taksdal T, Wasmuth MA, Gjerset B, Brun E, Olsen AB, Breck O,
Sandberg M. Salmonid alphavirus (SAV) and pancreas disease (PD) in
Atlantic salmon, Salmo salar L., in freshwater and seawater sites in Norway
from 2006 to 2008. J Fish Dis. 2010;33:391–402.
10. Hjortaas MJ, Skjelstad HR, Taksdal T, Olsen AB, Johansen R, Bang-Jensen B,
Orpetveit I, Sindre H. The first detections of subtype 2-related salmonid
alphavirus (SAV2) in Atlantic salmon, Salmo salar L., in Norway. J Fish Dis.
2013;36:71–4.
11. Taksdal T, Bang Jensen B, Böckerman I, McLoughlin MF, Hjortaas MJ, Ramstad A,
Sindre H: Mortality and weight loss of Atlantic salmon, Salmon salar L.,
experimentally infected with salmonid alphavirus subtype 2 and subtype 3
isolates from Norway. J Fish Dis. 2015;38:1047-61.
12. Jansen MD, Jensen BB, Brun E. Clinical manifestations of pancreas disease
outbreaks in Norwegian marine salmon farming – variations due to salmonid
alphavirus subtype. J Fish Dis. 2015;38:343–53.
13. Hoar WS. The physiology of smolting salmonids. In: Hoar XIB, WSR DJ,
editors. Fish Physiology. New York: Academic; 1988. p. 275–343.
14. McCormick SD, Sheehan TF, Björnsson BT, Lipsky C, Kocik JF, Regish AM,
O'Dea MF. Physiological and endocrine changes in Atlantic salmon smolts
during hatchery rearing, downstream migration, and ocean entry. Can J Fish
Aquat Sci. 2013;70:105–18.
Jarungsriapisit et al. Virology Journal  (2016) 13:66 Page 13 of 14
15. McCormick SD. Methods for nonlethal gill biopsy and measurement of Na+,
K+ -ATPase activity. Can J Fish Aquat Sci. 1993;50:656–8.
16. Haney DC, Hursh DA, Mix MC, Winton JR. Physiological and hematological
changes in Chum salmon artificially infected with erythrocytic necrosis virus.
J Aquat Anim Health. 1992;4:48–57.
17. Pettersen EF, Ulvenes M, Melingen GO, Wergeland HI. Peripheral blood and
head kidney leucocyte populations during out-of-season (0+) parr-smolt
transformation and seawater transfer of Atlantic salmon (Salmo salar L.). Fish
Shellfish Immun. 2003;15:373–85.
18. Melingen GO, Stefansson SO, Berg A, Wergeland HI. Changes in serum protein
and IgM concentration during smolting and early post-smolt period in
vaccinated and unvaccinated Atlantic salmon (Salmo salar L). Fish Shellfish
Immun. 1995;5:211–21.
19. Andersen L, Bratland A, Hodneland K, Nylund A. Tissue tropism of salmonid
alphaviruses (subtypes SAV1 and SAV3) in experimentally challenged
Atlantic salmon (Salmo salar L.). Arch Virol. 2007;152:1871–83.
20. Andersen L, Hodneland K, Nylund A. No influence of oxygen levels on
pathogenesis and virus shedding in Salmonid alphavirus (SAV)-challenged
Atlantic salmon (Salmo salar L.). Virol J. 2010;7:198.
21. Christie KE, Graham DA, McLoughlin MF, Villoing S, Todd D, Knappskog D.
Experimental infection of Atlantic salmon Salmo salar pre-smolts by i.p.
injection with new Irish and Norwegian salmonid alphavirus (SAV) isolates: a
comparative study. Dis Aquat Organ. 2007;75:13–22.
22. Xu C, Mutoloki S, Evensen O. Superior protection conferred by inactivated
whole virus vaccine over subunit and DNA vaccines against salmonid
alphavirus infection in Atlantic salmon (Salmo salar L.). Vaccine.
2012;30:3918–28.
23. Graham DA, Frost P, McLaughlin K, Rowley HM, Gabestad I, Gordon A,
McLoughlin MF. A comparative study of marine salmonid alphavirus
subtypes 1-6 using an experimental cohabitation challenge model. J Fish
Dis. 2011;34:273–86.
24. Grove S, Austbo L, Hodneland K, Frost P, Lovoll M, McLoughlin M, Thim HL,
Braaen S, Konig M, Syed M, et al. Immune parameters correlating with
reduced susceptibility to pancreas disease in experimentally challenged
Atlantic salmon (Salmo salar). Fish Shellfish Immun. 2013;34:789–98.
25. Björnsson BT, Hemre G-I, Bjørnevik M, Hansen T. Photoperiod regulation of
plasma growth hormone levels during induced smoltification of underyearling
Atlantic Salmon. Gen Comp Endocr. 2000;119:17–25.
26. Handeland SO, Stefansson SO. Effects of salinity acclimation on pre-smolt
growth, smolting and post-smolt performance in off-season Atlantic salmon
smolts (Salmo salar L.). Aquaculture. 2002;209:125–37.
27. Xu C, Guo T-C, Mutoloki S, Haugland Ø, Marjara IS, Evensen Ø. Alpha interferon
and not gamma interferon inhibits salmonid alphavirus subtype 3 replication
in vitro. J Virol. 2010;84:8903–12.
28. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints.
Am J Epidemiol. 1938;27:493–7.
29. McBeath AJA, Snow M, Secombes CJ, Ellis AE, Collet B. Expression kinetics of
interferon and interferon-induced genes in Atlantic salmon (Salmo salar)
following infection with infectious pancreatic necrosis virus and infectious
salmon anaemia virus. Fish Shellfish Immun. 2007;22:230–41.
30. Goyal SM, Gerba CP. Viradel method for detection of rotavirus from seawater.
J Virol Methods. 1983;7:279–85.
31. Wallis C, Henderso M, Melnick JL. Enterovirus concentration on cellulose
membranes. Appl Microbiol. 1972;23:476–80.
32. Polaczyk AL, Roberts JM, Hill VR. Evaluation of 1MDS electropositive microfilters
for simultaneous recovery of multiple microbe classes from tap water.
J Microbiol Meth. 2007;68:260–6.
33. Sobsey MD, Glass JS. Poliovirus concentration from tap water with electropositive
adsorbent filters. Appl Environ Microb. 1980;40:201–10.
34. Hodneland K, Endresen C. Sensitive and specific detection of Salmonid
alphavirus using real-time PCR (TaqMan (R)). J Virol Methods. 2006;131:184–92.
35. Olsvik P, Lie K, Jordal A-E, Nilsen T, Hordvik I. Evaluation of potential
reference genes in real-time RT-PCR studies of Atlantic salmon. BMC Mol
Biol. 2005;6:21.
36. Stefansson SO, Björnsson BT, Sundell K, Nyhammer G, McCormick SD.
Physiological characteristics of wild Atlantic salmon post-smolts during
estuarine and coastal migration. J Fish Biol. 2003;63:942–55.
37. Graham DA, Brown A, Savage P, Frost P. Detection of salmon pancreas
disease virus in the faeces and mucus of Atlantic salmon, Salmo salar L., by
real-time RT-PCR and cell culture following experimental challenge. J Fish
Dis. 2012;35:949–51.
38. McLoughlin MF, Graham DA, Norris A, Matthews D, Foyle L, Rowley HM,
Jewhurst H, MacPhee J, Todd D. Virological, serological and
histopathological evaluation of fish strain susceptibility to experimental
infection with salmonid alphavirus. Dis Aquat Organ. 2006;72:125–33.
39. Xu C, Guo TC, Mutoloki S, Haugland O, Evensen O. Gene expression studies
of host response to Salmonid alphavirus subtype 3 experimental infections
in Atlantic salmon. Vet Res. 2012;43:10.
40. Taksdal T, Olsen AB, Bjerkås I, Hjortaas MJ, Dannevig BH, Graham DA,
McLoughlin MF. Pancreas disease in farmed Atlantic salmon, Salmo salar L.,
and rainbow trout, Oncorhynchus mykiss (Walbaum), in Norway. J Fish Dis.
2007;30:545–58.
41. LaPatra SE. Factors affecting pathogenicity of infectious hematopoietic
necrosis virus (IHNV) for salmonid fish. J Aquat Anim Health. 1998;10:121–31.
42. Glover KA, Skår C, Christie KE, Glette J, Rudra H, Skaala Ø. Size-dependent
susceptibility to infectious salmon anemia virus (ISAV) in Atlantic salmon (Salmo
salar L.) of farm, hybrid and wild parentage. Aquaculture. 2006;254:82–91.
43. Fridell F, Gadan K, Sundh H, Taranger GL, Glette J, Olsen RE, Sundell K,
Evensen O. Effect of hyperoxygenation and low water flow on the primary
stress response and susceptibility of Atlantic salmo Salmo salar L. to
experimental challenge with IPN virus. Aquaculture. 2007;270:23–35.
44. Nilsen TO, Ebbesson LOE, Kiilerich P, Björnsson BT, Madsen SS, McCormick SD,
Stefansson SO. Endocrine systems in juvenile anadromous and landlocked
Atlantic salmon (Salmo salar): Seasonal development and seawater
acclimation. Gen Comp Endocr. 2008;155:762–72.
45. Heidari Z, Tinsley J, Bickerdike R, McLoughlin ME, Zou J, Martin SAM. Antiviral
and metabolic gene expression responses to viral infection in Atlantic salmon
(Salmo salar). Fish Shellfish Immun. 2015;42:297–305.
46. Specker JL, Portesi DM, Cornell SC, Veillette PA. Methodology for implanting
cortisol in Atlantic salmon and effects of chronically elevated cortisol on
osmoregulatory physiology. Aquaculture. 1994;121:181–93.
Jarungsriapisit et al. Virology Journal  (2016) 13:66 Page 14 of 14
